Christopher M. Starr, Chief Executive Officer at Raptor Pharmaceutical Corp (RPTP), sold 30,000 shares at $8.15 ($245K) on 2014-12-15, disclosed to the SEC on 2014-12-17.
Scheduled sale ($244k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RPTP | SELL | 2015-03-18 | $352K | — | Filing → |
| RPTP | SELL | 2015-02-25 | $286K | — | Filing → |
| RPTP | SELL | 2015-02-19 | $281K | — | Filing → |